Brief: Aurobindo Pharma Q2 Consol Net Profit 8.48 Billion Rupees
05/11/2025 14:24
Nov 5 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA Q2 CONSOL NET PROFIT 8.48 BILLION RUPEES AUROBINDO PHARMA Q2 CONSOL TOTAL REVENUE FROM OPERATIONS 82.86 BILLION RUPEES Source text: [ID:] Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11